These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 19425326

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Management of hepatocellular carcinoma.
    Del Pozo AC, López P.
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tace treatment outcome: (almost) everything is predictable.
    Giannelli G, Vella FS, Antonaci S, Foti C, Filotico R.
    Dig Liver Dis; 2006 Dec; 38(12):940-1. PubMed ID: 16880014
    [No Abstract] [Full Text] [Related]

  • 27. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease.
    Strebel BM, Dufour JF.
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1743-9. PubMed ID: 18983234
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Regression of hepatocellular carcinoma with right atrial extension after sorafenib and transarterial chemoembolization.
    Subramanian M, Singal AG, Yopp AC.
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):e83-4. PubMed ID: 22813441
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Advanced hepatocellular carcinoma].
    Okazaki M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():417-21. PubMed ID: 11761984
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy?
    Di Benedetto F, Berretta M, De Ruvo N, Tarantino G, D'Amico G, Ballarin R, Iemmolo RM, Gerunda GE.
    J Surg Oncol; 2012 Jan; 105(1):111-2. PubMed ID: 21792942
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.